ClinicalTrials.gg
RecruitingNCT07151573Updated Oct 1, 2025

Evaluating the Big Five Intervention in Norway

An interventional study of Big Five and Gratitude in Anxiety Depression, sponsored by Haukeland University Hospital. Recruiting at 2 sites in Norway. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2025-10-01.

Primary conditionAnxiety Disorders(the registry's first term)UnverifiedIs this wrong?The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it. No better condition is named, so the registry's term is kept.

Sponsored by Haukeland University Hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2026, 4 months ago, but the record still lists the study as recruiting.
  • Started Sep 2025; still recruiting 1 year 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
410
Allocation
Randomized
Ages
16 Years and older
Sex
All
01

Study summary

This randomized controlled trial will evaluate the Norwegian adaptation of the Big Five intervention (Things You Do; TYD) for individuals with self-reported anxiety and/or depressive symptoms. The study will compare the Big Five intervention with a Gratitude intervention and a waitlist control. A total of 410 participants will be recruited online and randomized to one of three groups. Intervention groups will receive a brief module and daily SMS reminders (Monday-Friday for four weeks) encouraging engagement in either the five daily actions or gratitude practices. The primary aim is to replicate findings from the Australian trial by comparing TYD to a waitlist control. A secondary aim is to examine whether TYD yields better outcomes than the active Gratitude control. This study will provide evidence on the effectiveness and cross-cultural applicability of a low-cost, scalable intervention for improving mental health. Data from the study will also be used to evaluate the psychometric properties of the Norwegian translation of the Things You Do-15 instrument (TYD-15).

Read the detailed description

Researchers in Australia have identified five central daily actions that are associated with mental health and may account for 37 % of the variance in anxiety and depressive symptoms: Healthy thinking, Meaningful Activities, Goals and Plans, Healthy Habits, and Social Connections. Conducting these actions more than three to four times a week may improve symptoms of anxiety and depression. Aim: The current study aims to replicate the findings from the Australian developers by adapting the intervention to a Norwegian context in a randomized controlled trial.

02

Conditions studied

  • Anxiety Depression

Browse trials for

Keywords

  • Anxiety
  • Internet interventions
  • Big Five
  • DIgital Mental Health Intervention
  • Preventive interventions
03

In context

Anxiety Disorders Unverified

7,242 studies on the registry are indexed under Anxiety Disorders; 1,691 are open to participants now.

This study's planned enrollment of 410 is above the median of 80 across 6,103 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Haukeland University Hospital is the lead sponsor of 284 studies on the registry; 58 are open to participants now.

Compared within Anxiety Disorders, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • PHQ or GAD cutoff 5 or above
  • Residing in Norway and have a Norwegian national identity number
  • 16 years or above

Exclusion criteria

Exclusion Criteria:

  • Reporting 2 or higher on PHQ item 9 (suicidality concerns)
  • Do not comprehend Norwegian or English
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
410 participants (estimated)

Study arms

  • Experimental
    Big Five

    Other: Big Five

  • Active comparator
    Gratitude

    Other: Gratitude

  • No intervention
    Waitlist

    Waitlist during the intervention period, and receive Big Five on week 5.

Interventions

  • OtherBig Five

    The intervention is self-guided and consists of a brief 14-page psychoeducation module that they are introduced to in the beginning of a 4-week intervention period (day 0). The module starts with a general introduction to mental health and Things you do action and how it promotes mental health. The final section presents the five core actions: 1) healthy thinking, 2) meaningful activities, 3) goals and plans, 4) healthy habits, and 5) social connections. Participants are advised to engage in the five daily actions throughout the intervention period. They are also encouraged to fill out a weekly planner and monitor their progress by keeping an overview of the number of daily activities in "My Week".The participants receive the module on a Sunday (Day 0). They receive text reminders Monday to Friday for four weeks, encouraging them to engage in the actions.

    Also known as: TYD

  • OtherGratitude

    The intervention is self-guided and consists of a brief 14-page psychoeducation module that they are introduced to in the beginning of a 4-week intervention period (day 0). The module starts with a general introduction to mental health and Gratitude and how it promotes mental health, followed by a short summary on the benefits of gratitude. The final section introduces practical strategies for cultivating gratitude by focusing on five key gratitude activities: 1) keeping a gratitude journal, 2) expressing gratitude to others, 3) finding gratitude in misfortune or difficult situations, 4) appreciating good things and 5) another perspective. The participants receive the module on a Sunday (Day 0). They receive text reminders Monday to Friday for four weeks, encouraging them to engage in the actions.

06

What researchers measure

Primary outcomes

  1. Generalized Anxiety Disorder- 7

    the scale measures measure anxiety symptoms over the last two weeks. The questionnaire consists of seven items on a 4-point Likert Scale ranging from 0 (Not at all) to 3 (Nearly every day), giving a minimum score of 0 and maximum 21. Higher scores indicate more anxiety symptoms.

    Time frame: At Screening

  2. Patient Health Questionnaire - 2

    The scale measures depressive symptoms symptoms over the last two weeks. The questionnaire consists of two items on a 4-point Likert Scale ranging from 0 (Not at all) to 3 (Nearly every day), giving a minimum score of 0 and maxiumum 6. Higher scores indicate more depressive symptoms.

    Time frame: At pre, day 8, day 15, day 22, post, follow-up 3, 6, and 12 months

  3. Patient Health Questionnaire - 9

    The scale measures depressive symptoms symptoms over the last two weeks. The questionnaire consists of nineitems on a 4-point Likert Scale ranging from 0 (Not at all) to 3 (Nearly every day), giving a minimum score of 0 and maximum 27. Higher scores indicate more depressive symptoms.

    Time frame: At screening

  4. Generalized Anxiety Disorder - 2

    The scale measures anxiety symptoms symptoms over the last two weeks. The questionnaire consists of two items on a 4-point Likert Scale ranging from 0 (Not at all) to 3 (Nearly every day), giving a minimum score of 0 and maxiumum 6. Higher scores indicate more anxiety symptoms.

    Time frame: At pre, day 8, day 15, day 22, post, follow-up 3, 6, and 12 months

Secondary outcomes

  1. Satisfaction With Life Scale

    The scale measure subjective well-being and life satisfaction. The questionnaire consists of five items on a 7-point Likert scale ranging from 1 (Strongly disagree) to 7 (Strongly agree), giving a minimum sum score of 5 and maximum 35. Higher scores indicate greater life satisfaction.

    Time frame: From pre, peri intervention, post, and follow-up 3, 6 and 12 months

Other outcomes

  1. Gratitude Questionnaire

    The scale measure their experience of gratitude. The questionnaire consists of 6 items on a 7-point Likert scale ranging from 1 (strongly disagree) to 7 (strongly agree), with two of the questions being reversed scored, giving a minimum sum score of 6 and a maximum score of 42. Higher scores indicate greater experience of gratitude.

    Time frame: From pre, peri intervention, post, and follow-up 3, 6 and 12 months

  2. Things You Do-15 Questionnaire

    TYD.15 measure their engagement in the daily actions that are associated with emotional wellbeing. The questionnaire comprises of 15 items on a scale from 0 to 4, giving a minimum sum score of 0 and maximum 60. Higher sum scores indicate greater engagement in daily actions.

    Time frame: At screening, pre, peri intervention, post, and follow-up 3, 6 and 12 months

  3. Motivation for change in daily life - Questionnaire

    The scale measure their motivation and the importance of making changes in habits, readiness to change, and confidence in that they can make changes. The questionnaire consists of total 4 items on a scale from 1 to 10. Higher score on each item indicate greater motivation

    Time frame: day 8

  4. Credibility

    Credibility is a 1-item assessment measuring whether they would recommend the intervention to a friend on a scale from 1 to 9. Higher score indicate greater credibility.

    Time frame: day 8, post

07

Study locations

1 of 2 sites recruiting
  • Research centre for digital mental health services
    Bergen, Vestland 5009, Norway
    Not yet recruiting
  • Research Centre For Digital Mental Health Services - Haukeland University Hospital
    Bergen, 5009, Norway
    Recruiting
    • Smiti Kahlon, PhD · Contact+47 98866640
    • Smiti Kahlon, PhD · Principal investigator
    • Emilie Sektnan Nordby, PhD · Sub investigator
08

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol, Statistical analysis plan, Analytic code

Time frame: When data collection ends

Access criteria: IPD will be made available from PI on reasonable request and according to relevant Norwegian laws and regulations

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2025 (actual). Primary completion is estimated for Jun 2026, 9 months after the start.

Of 3,871 non-industry interventional studies with no phase under Anxiety Disorders, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's planned 9 months is below that.

Counting every sponsor, half of 3,976 studies reached it within 12 months; a quarter within 5 and three quarters within 28.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 22, 2025
First posted
Sep 3, 2025
StartActual
Sep 10, 2025
Primary completionEst.
Jun 30, 2026
CompletionEst.
Sep 30, 2027
Last update
Oct 1, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07151573
Collaborators
The Research Council of Norway
Responsible party
Sponsor
First posted
Sep 3, 2025
Start date
Sep 10, 2025
Primary completion
Jun 30, 2026 (estimated)
Completion
Sep 30, 2027 (estimated)
Last update
Oct 1, 2025

Study contacts

Smiti Kahlon, PhD
Contact
smiti.kahlon@helse-bergen.no
+4798866640
Tine Nordgreen, Professor
Contact

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion